As year-end deadline looms, Congress again calls on DEA to extend telehealth flexibilities

​Bipartisan lawmakers say a temporary extension isn’t adequate, and they’re concerned that the draft proposal is “misaligned with Congressional intent” with regard to a registry for the prescribing of controlled substances via telemedicine.